Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
TMOS34.SA
BuyThermo Fisher Scientific Inc. · Healthcare · United States · $229.1B · Avg Vol: $29K/d
79
StockRankGet insider-trade alerts
Q
57
V
41
M
76
P/E (TTM)
33.7x
ROE
13.5%
D/E
0.8x
Dividend %
0.2%
COMPANY DESCRIPTION
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally.
FINANCIAL SUMMARY (BRL)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 233.8B | 223.1B | 223.2B | 232.0B | -0.3% | 241.2B | 249.2B | 262.0B | 6.3% |
| EPS (BRL) | 0.04 | 0.04 | 0.04 | 0.04 | -1.2% | — | — | — | — |
| Shares | 17.7B | 17.7B | 17.7B | 17.7B | 0.0% | 17.7B | — | — | — |
| Debt | 179.5B | 181.8B | 162.8B | 205.0B | 4.5% | 221.5B | — | — | — |
| Equity | 228.9B | 243.3B | 258.1B | 278.0B | 6.7% | — | — | — | — |
| Op CF | 47.7B | 43.8B | 45.1B | 40.7B | -5.1% | 46.9B | — | — | — |
| Inv CF | -11.2B | -26.8B | -30.4B | -21.1B | — | — | — | — | — |
| Fin CF | -14.6B | -18.9B | -35.4B | 9.4B | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)+20.4%
SMA 50SMA 200
Close
$12.91
RSI (14)
68.3
52W High
$13.81
From 52W High
0.9%
SCORE BREAKDOWN
Quality
57
ROIC
9.6%72.5
ROE
13.5%79.4
GP/Assets
17.2%40.3
Op. Margin
18.8%80.4
FCF/Assets
6.6%75.2
Piotroski
550.0
Int. Cover
6.2x55.8
D/E Ratio
0.81x19.1
Current Ratio
1.55x28.3
Value
41
P/E (TTM)
33.7x34.7
EV/EBITDA
20.2x31.7
P/FCF
31.3x42.6
P/B
0.9x88.1
P/S
5.0x43.4
Div Yield
0.2%1.9
Momentum
76
52W High %
93%88.8
RS 6M
28%84.4
SMA 50/200
1.03x66.3
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
7%46.2
FUNDAMENTALS
Market Cap
$229.1B
P/E (Forward)
—
Gross Margin
41.0%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of TMOS34.SA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| TMOS34.SA | Thermo Fisher Scientific Inc.(you) | $229.1B | 79 | Buy |
| DHER34.SA | Danaher Corporation | $151.9B | 76 | Buy |
| 603259.SS | WuXi AppTec Co., Ltd. | $69.9B | 80 | Strong Buy |
| IQV | IQVIA Holdings Inc. | $43.1B | 78 | Buy |
| IDXX.MX | IDEXX Laboratories, Inc. | $43.9B | 73 | Buy |
| A | Agilent Technologies, Inc. | $43.4B | 73 | Buy |
| ILMN | Illumina, Inc. | $32.6B | 78 | Buy |
| LONN.SW | Lonza Group AG | $50.4B | 61 | Hold |
| DGX | Quest Diagnostics Incorporated | $26.8B | 85 | Strong Buy |
| LH | Labcorp Holdings Inc. | $27.2B | 86 | Strong Buy |
Peer medians: ROE 2.0% · P/E 24.1x · Gross margin 52.6%